1. Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma
   Paola Caria et al, 2016, International Journal of Molecular Sciences CrossRef
2. Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
   Ismail Hosen et al, 2015, International Journal of Cancer CrossRef
3. Correlation of telomere length to malignancy potential in non‑melanoma skin cancers
   Hanae Yamada‑Hishida et al, 2017, Oncology Letters CrossRef
4. EGFR and HER2 Expression in Papillary Thyroid Carcinoma
   Yong-Seon Kim et al, 2018, Journal of Endocrine Surgery CrossRef
5. Biological Differential Diagnosis of Follicular Thyroid Tumor and Hürthle Cell Tumor on the Basis of Telomere Length and hTERT Expression
   Yoshiyuki Sugishita et al, 2014, Annals of Surgical Oncology CrossRef
6. Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer
   WOJCIECH BARCZAK et al, 2016, Oncology Letters CrossRef
7. HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
   Rosaria Ruggeri et al, 2016, International Journal of Molecular Sciences CrossRef
8. Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
   Valerie Jacquemin et al, 2022, Cancers CrossRef